DK0862577T3 - Sulfamatderivater af 1,3,5(10)-estratrien-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der - Google Patents

Sulfamatderivater af 1,3,5(10)-estratrien-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der

Info

Publication number
DK0862577T3
DK0862577T3 DK96945140T DK96945140T DK0862577T3 DK 0862577 T3 DK0862577 T3 DK 0862577T3 DK 96945140 T DK96945140 T DK 96945140T DK 96945140 T DK96945140 T DK 96945140T DK 0862577 T3 DK0862577 T3 DK 0862577T3
Authority
DK
Denmark
Prior art keywords
derivatives
preparation
pharmaceutical preparations
estratrien
sulfamate
Prior art date
Application number
DK96945140T
Other languages
Danish (da)
English (en)
Inventor
Sigfrid Schwarz
Gudrun Reddersen
Birgitt Schneider
Ina Thieme
Margit Richter
Walter Elger
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Application granted granted Critical
Publication of DK0862577T3 publication Critical patent/DK0862577T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK96945140T 1995-10-19 1996-09-19 Sulfamatderivater af 1,3,5(10)-estratrien-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der DK0862577T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19540233A DE19540233B4 (de) 1995-10-19 1995-10-19 Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
PCT/DE1996/001823 WO1997014712A2 (de) 1995-10-19 1996-09-19 Sulfamat-derivate von 1,3,5(10)-estratrien-derivaten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen

Publications (1)

Publication Number Publication Date
DK0862577T3 true DK0862577T3 (da) 1999-10-25

Family

ID=7776061

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96945140T DK0862577T3 (da) 1995-10-19 1996-09-19 Sulfamatderivater af 1,3,5(10)-estratrien-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der

Country Status (13)

Country Link
EP (1) EP0862577B1 (ja)
JP (2) JPH11505268A (ja)
KR (1) KR100306044B1 (ja)
CN (1) CN1125077C (ja)
AT (1) ATE178903T1 (ja)
AU (1) AU1436097A (ja)
BR (1) BR9610905A (ja)
DE (2) DE19540233B4 (ja)
DK (1) DK0862577T3 (ja)
ES (1) ES2131972T3 (ja)
GR (1) GR3030733T3 (ja)
RU (1) RU2159774C2 (ja)
WO (1) WO1997014712A2 (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
US6288050B1 (en) * 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
ES2310943T3 (es) 1998-06-10 2009-01-16 Sterix Limited Composicion farmaceutica con factor de necrosis tumoral a y 2-metoxiestrona-3-o-sulfamato para la inhibicion de la estrona sulfatasa.
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
DE19943708B4 (de) * 1999-09-08 2007-12-20 Bayer Schering Pharma Ag Neue C13-substituierte Estra-1,3,5(10)-trien-3-yl-sulfamate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US6583130B1 (en) 1999-09-13 2003-06-24 Schering Ag C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
EP1769799A3 (en) * 2000-01-14 2010-01-13 Sterix Limited Pharmaceutical compositions containing steroidal structures and uses thereof
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE10139494A1 (de) * 2001-08-13 2003-03-06 Jenapharm Gmbh Antitumor wirksame 2-Alkoxyestradiolsulfamate
US8026229B2 (en) 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
DE10307104A1 (de) 2003-02-19 2004-09-23 Schering Ag Antitumor wirksame 2-substituierte Estra-1,3,5(10)-trien-3-yl sulfamate
DE10307103A1 (de) 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
DE10307105A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte 18a-Homoestra-1,3,5(10)-trien-3-yl sulfamate
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
US20080292765A1 (en) * 2007-05-22 2008-11-27 The Coca-Cola Company Sweetness Enhancers, Sweetness Enhanced Sweetener Compositions, Methods for Their Formulation, and Uses
GB201302368D0 (en) * 2013-02-11 2013-03-27 Univ Bath Compound
RU2562242C1 (ru) * 2014-07-10 2015-09-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный университет" (СПбГУ) РАЦЕМИЧЕСКИЙ 2,17β-ДИСУЛЬФАМОИЛОКСИ-3-МЕТОКСИ-8α-ЭСТРА-1,3,5(10)-ТРИЕН В КАЧЕСТВЕ ИНГИБИТОРА ПРОЛИФЕРАЦИИ ОПУХОЛЕВЫХ КЛЕТОК MCF-7

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2133484A2 (en) * 1969-04-29 1972-12-01 Jenapharm Veb 3-17 and 21-sulphonyloxy-steroids - with androgenic anabolic progestogenic and oestrogen activity of long duration
IL94183A (en) * 1989-05-05 2003-09-17 Baylor College Medicine cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE
EP0429628B1 (en) * 1989-06-16 1998-09-02 Genencor International, Inc. Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi
JP2818056B2 (ja) * 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
ZA932568B (en) * 1992-04-24 1993-11-12 Baylor College Midecine A Non Production of recombinant human lactoferrin

Also Published As

Publication number Publication date
CN1200126A (zh) 1998-11-25
DE59601683D1 (de) 1999-05-20
WO1997014712A3 (de) 1997-06-05
DE19540233A1 (de) 1997-04-24
WO1997014712A2 (de) 1997-04-24
RU2159774C2 (ru) 2000-11-27
DE19540233B4 (de) 2005-08-25
ATE178903T1 (de) 1999-04-15
BR9610905A (pt) 1999-07-13
CN1125077C (zh) 2003-10-22
KR19990064144A (ko) 1999-07-26
JP3040175B2 (ja) 2000-05-08
AU1436097A (en) 1997-05-07
KR100306044B1 (ko) 2001-12-05
ES2131972T3 (es) 1999-08-01
JPH11505268A (ja) 1999-05-18
GR3030733T3 (en) 1999-11-30
EP0862577B1 (de) 1999-04-14
EP0862577A2 (de) 1998-09-09

Similar Documents

Publication Publication Date Title
DK0862577T3 (da) Sulfamatderivater af 1,3,5(10)-estratrien-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der
DK165004C (da) Sulfamatderivater og farmaceutiske praeparater indeholdende disse
DK0503548T3 (da) Cykliske ureaderivater, lægemidler indeholdende disse, og fremgangsmåde til deres fremstilling.
DK295984A (da) 2-pyrimidinyl-1-piperazin-derivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende dem
FI901530A0 (fi) Menetelmä immunomoduloivien atsaspiraanien valmistamiseksi
HUP0001192A2 (hu) Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
EE05091B1 (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
DK0434057T3 (da) Indocarbazol-derivater, fremgangsmåder til deres fremstilling og deres anvendelse
YU9502A (sh) Polimorfi torzemida
NO952205L (no) Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter
NO995431D0 (no) Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
DK441180A (da) 2-hydroxyalkyl-3,4,5-trihydroxypiperidiner deres fremstilling og anvendelse
DK0906329T3 (da) 2'-Substituerede nukleosider og oligonukleotidderivater
DK0443918T3 (da) Hidtil ukendte derivater af 20,21-dinoreburnamenin, deres fremstilling og anvendelse som lægemidler, samt mellemprodukter og farmaceutiske peæparater med indhold heraf
DK0505400T3 (da) N-substituerede naphthalimider, deres fremstilling og anvendelse
DK405884A (da) Spiro(benzofuran-azalkaner), fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
BG101722A (en) New cumarine derivatives, methods for their preparation and application
DK0552758T3 (da) N-5-Beskyttede 2,5-diamino-4,6-dichlorpyrimidiner og fremgangsmåde til deres fremstilling
HUT43614A (en) Process for producing isohexide-nucleosides and pharmaceutical compositions containing them
DK0809627T3 (da) Hidtil ukendte borneolderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
DK0427125T3 (da) Benzylselenobenzamider af aniliner og benzylaminer
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
DK0427160T3 (da) Benzylselenobenzamid af aminopyridiner og picolylaminer